Latigo Biotherapeutics, Inc.

📍 Thousand Oaks, United States👥 36 employees💰 Last funded Nov 2024
Biotechnology Research🌐 latigobio.com
Website LinkedIn
Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Latigo Biotherapeutics, Inc.?
Latigo Biotherapeutics, Inc. has 1 investors on record on gritt.io.
When did Latigo Biotherapeutics, Inc. last raise funding?
The most recent investment in Latigo Biotherapeutics, Inc. recorded on gritt.io was in November 2024.
What industry is Latigo Biotherapeutics, Inc. in?
Latigo Biotherapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Latigo Biotherapeutics, Inc. based?
Latigo Biotherapeutics, Inc. is headquartered in Thousand Oaks, United States.